Paper8656342
Risk assessment of adverse pulmonary effects induced by adrenaline beta-receptor antagonists and rational drug dosage regimen based on receptor occupancy.
Yamada Y and 4 others. J Pharmacokinet Biopharm, 1995. Cited by 13 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Risk assessment of adverse pulmonary effects induced by adrenaline beta-receptor antagonists and rational drug dosage regimen based on receptor occupancy. Papers, record 8656342. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8656342
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Risk assessment of adverse pulmonary effects induced by adrenaline beta-receptor antagonists and rational drug dosage regimen based on receptor occupancy.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adrenergic beta-Antagonists | Major topic |
| Lung | Major topic |
| Receptors, Adrenergic, beta | Major topic |
| Dose-Response Relationship, Drug | |
| Forced Expiratory Volume | |
| Heart Rate | |
| Humans | |
| Models, Biological | |
| Nonlinear Dynamics | |
| Risk Assessment |
Source PubMed
References23
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1,376,792 | Spare receptors for beta-adrenoceptor-mediated positive inotropic effects of catecholamines in the human heart. | J Cardiovasc Pharmacol | 1992 | https://conductscience.org/library/papers/1376792 | PubMed |
| 2 | 25,075 | Beta-blockers and asthma. | Br Heart J | 1978 | https://conductscience.org/library/papers/25075 | PubMed |
| 3 | 2,859,024 | Receptor binding characteristics and pharmacokinetic properties as a tool for the prediction of clinical effects of beta-blockers. | Arzneimittelforschung | 1985 | https://conductscience.org/library/papers/2859024 | PubMed |
| 4 | 2,892,986 | Beta-adrenergic blockers. | Med Clin North Am | 1988 | https://conductscience.org/library/papers/2892986 | PubMed |
| 6 | 2,886,244 | Clinical pharmacokinetics of beta-adrenoceptor antagonists. An update. | Clin Pharmacokinet | 1987 | https://conductscience.org/library/papers/2886244 | PubMed |
| 7 | 3,450,842 | Propranolol pharmacodynamic modeling using unbound and total concentrations in healthy volunteers. | J Pharmacokinet Biopharm | 1987 | https://conductscience.org/library/papers/3450842 | PubMed |
| 8 | 738,350 | Plasma timolol levels after oral and intravenous administration. | Eur J Clin Pharmacol | 1978 | https://conductscience.org/library/papers/738350 | PubMed |
| 9 | 6,102,500 | Pharmacokinetic and pharmacodynamic properties of metoprolol in patients with impaired renal function. | Clin Pharmacokinet | 1980 | https://conductscience.org/library/papers/6102500 | PubMed |
| 10 | 1,175,271 | Correlation of plasma propranolol concentration with therapeutic response in patients with angina pectoris. | Circulation | 1975 | https://conductscience.org/library/papers/1175271 | PubMed |
| 11 | 1,973,398 | [Pharmacological studies of celiprolol: I. Beta-blocking effect, intrinsic sympathomimetic activity, vasodilating and hypotensive effects]. | Nihon Yakurigaku Zasshi | 1990 | https://conductscience.org/library/papers/1973398 | PubMed |
| 12 | 2,882,776 | Effect of beta-adrenoceptor blockade on exercise-induced plasma catecholamine concentrations and their dissipation profile. | Br J Clin Pharmacol | 1987 | https://conductscience.org/library/papers/2882776 | PubMed |
| 13 | 2,903,820 | Bisoprolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and angina pectoris. | Drugs | 1988 | https://conductscience.org/library/papers/2903820 | PubMed |
| 14 | 4,853,602 | Pharmacokinetics of pindolol in man. | Eur J Clin Pharmacol | 1974 | https://conductscience.org/library/papers/4853602 | PubMed |
| 15 | 7,328,489 | A pharmacokinetic analysis program (multi) for microcomputer. | J Pharmacobiodyn | 1981 | https://conductscience.org/library/papers/7328489 | PubMed |
| 16 | 1,094,802 | Combined pharmacokinetic and pharmacodynammc studies in man of the adrenergic beta1-receptor antagonist metoprolol. | Acta Pharmacol Toxicol (Copenh) | 1975 | https://conductscience.org/library/papers/1094802 | PubMed |
| 18 | 3,000,793 | Receptor binding of propranolol is the missing link between plasma concentration kinetics and the effect-time course in man. | Eur J Clin Pharmacol | 1985 | https://conductscience.org/library/papers/3000793 | PubMed |
| 19 | 4,155,762 | Pharmacokinetic studies on the selective beta1-receptor antagonist metoprolol in man. | J Pharmacokinet Biopharm | 1974 | https://conductscience.org/library/papers/4155762 | PubMed |
| 20 | 2,515,395 | Do pharmacological methods for the quantification of agonists work when the ternary complex mechanism operates? | J Theor Biol | 1989 | https://conductscience.org/library/papers/2515395 | PubMed |
| 21 | 6,105,819 | The clinical importance of cardioselectivity and lipophilicity in beta blockers. | Am Heart J | 1980 | https://conductscience.org/library/papers/6105819 | PubMed |
| 22 | 7,907,513 | Prediction of therapeutic doses of beta-adrenergic receptor blocking agents based on quantitative structure-pharmacokinetic/pharmacodynamic relationship. | Biol Pharm Bull | 1993 | https://conductscience.org/library/papers/7907513 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 28,887,613 | Theoretical method for evaluation of therapeutic effects and adverse effects of epidermal growth factor receptor tyrosine kinase inhibitors in clinical treatment. | Med Oncol | 2017 | https://conductscience.org/library/papers/28887613 | PubMed |
| 28,400,472 | Novel selective β1-adrenoceptor antagonists for concomitant cardiovascular and respiratory disease. | FASEB J | 2017 | https://conductscience.org/library/papers/28400472 | PubMed |
| 25,510,848 | Evaluation of clinical bradycardiac effect and respiratory adverse effect of β-blocking agents in coronary computed tomography angiography based on theoretical analysis. | Eur J Drug Metab Pharmacokinet | 2016 | https://conductscience.org/library/papers/25510848 | PubMed |
| 15,180,332 | Ocular pharmacokinetic/ pharmacodynamic modeling for bunazosin after instillation into rabbits. | Pharm Res | 2004 | https://conductscience.org/library/papers/15180332 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BDKRB1 | 623 | PubTator's text mining | https://conductscience.org/library/genes/623 | NCBI Gene |
| BDKRB2 | 624 | PubTator's text mining | https://conductscience.org/library/genes/624 | NCBI Gene |
| MS4A1 | 931 | PubTator's text mining | https://conductscience.org/library/genes/931 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8656342
GET https://conductscience.org/api/papers/v1/8656342/references?page=2